Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Eur J Heart Fail. 2018 Dec 10;21(3):286–296. doi: 10.1002/ejhf.1351

Table 2.

Doses of various interventions in heart failure clinical trials

Trial Drug Target Daily
Dose
Percent Reaching
Target
Mean
Daily Dose
V-HeFT [64] Hydralazine/Isosorbide dinitrate 112.5/160mg 55% 270mg/136mg
CONSENSUS [65] Enalapril 40mg - 18.4mg
SOLVD Treatment [11] Enalapril 20 mg - 16.6mg
MERIT-HF [13] Metoprolol CR/XL 200mg 64% 159mg
COPERNICUS [66] Carvedilol 50mg 80% 45mg
COMET [67] Metoprolol tartrate/ carvedilol 100/50mg 75%/78% 85mg/42 mg
RALES [14] Spironolactone 25mg - 26mg
CHARM-ALTERNATIVE [68] Candesartan 32mg - 23mg
A-HeFT [16] Hydralazine/Isosorbide dinitrate 225/120 mg 68% 143mg/76mg
EMPHASIS [69] Eplerenone 50mg 60.2% 39.1 mg